Publicação

GIScaSpA-study of subclinical gut involvement in axial spondyloarthritis

Detalhes bibliográficos
Autores principais:	Mazeda, Carolina
Outros Autores:	Silva, Susana P; Pinto Oliveira, C; Azevedo, Sofia; Barcelos, Anabela
Ano:	2024
País:	Portugal
Tipo de documento:	artigo
Tipo de acesso:	acesso aberto
Instituição associada:	Universidade Nova de Lisboa
Idioma:	inglês
Origem:	Repositório Institucional da UNL

Registos relacionados

Microspa – gut microbiota and axial spondyloarthritis : the impact on anti-tnf therapy
por: Rodrigues, Diana Margarida Tavares
Publicado em: (2023)

Axial Spondyloarthritis
por: Caetano, António Proença
Publicado em: (2021)

Sex differences in axial spondyloarthritis
por: Cunha, R. N.
Publicado em: (2022)

Sex differences in axial spondyloarthritis: data from a Portuguese spondyloarthritis cohort
por: Cunha, RN
Publicado em: (2022)

Axial Spondyloarthritis: Mimics and Pitfalls of Imaging Assessment
por: Caetano, A
Publicado em: (2021)

The role of muscle in the susceptibility and progression of axial Spondyloarthritis
por: Sardoo, Atlas Mashayekhi
Publicado em: (2021)

Spinal Radiographic Progression in Early Axial Spondyloarthritis
por: Ramiro, Sofia
Publicado em: (2019)

Biological DMARDs and disease modification in axial spondyloarthritis
por: Sepriano, Alexandre
Publicado em: (2021)

Muscle Evaluation in Axial Spondyloarthritis—The Evidence for Sarcopenia
por: Valido, Ana
Publicado em: (2019)

ASAS-EULAR recommendations for the management of axial spondyloarthritis
por: Ramiro, Sofia
Publicado em: (2022)

Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after two years?
por: Bento da Silva, Ana
Publicado em: (2025)

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis
por: Christiansen, Sara Nysom
Publicado em: (2024)

Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis
por: Pons, Marion
Publicado em: (2025)

Sacroiliac radiographic progression in recent onset axial spondyloarthritis
por: Dougados, Maxime
Publicado em: (2017)

Review of the updated definitions and concepts of spinal lesions in axial spondyloarthritis
por: Massignan, Â
Publicado em: (2024)

Second and third TNF inhibitors in European patients with axial spondyloarthritis
por: Linde, Louise
Publicado em: (2024)

Measuring quality of life of patients with axial spondyloarthritis for economic evaluation
por: Hernandez Alava, Monica
Publicado em: (2022)

Measuring quality of life of patients with axial spondyloarthritis for economic evaluation
por: Hernandez Alava, Monica
Publicado em: (2022)

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis
por: Manica, Santiago Rodrigues
Publicado em: (2020)

Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?
por: Felgueiras, H
Publicado em: (2016)

Change in different classes of chronic back pain suspicious of axial spondyloarthritis
por: Bosch, Philipp
Publicado em: (2024)

Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis
por: Marona, Jose
Publicado em: (2020)

Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 update
por: Machado, P.M.
Publicado em: (2017)

Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 update
por: Machado, P. M.
Publicado em: (2018)

TNF inhibitors reduce spinal radiographic progression in patients with radiographic axial spondyloarthritis
por: Sepriano, Alexandre
Publicado em: (2021)

Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis – 2016 update
por: Machado, P. M.
Publicado em: (2017)

Prevalence and clinical characteristics of late Onset Axial Spondyloarthritis: Results from a multicentre nationwide study
por: Rocha, Margarida Lucas
Publicado em: (2023)

The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis
por: Poddubnyy, Denis
Publicado em: (2025)

Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis
por: Ørnbjerg, Lykke M.
Publicado em: (2024)

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors
por: Ørnbjerg, Lykke M.
Publicado em: (2022)

Inflammation of the sacroiliac joints and spine on MRI predicts structural changes on MRI in axial spondyloarthritis
por: Sepriano, Alexandre
Publicado em: (2022)

5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis
por: Madari, Queeny
Publicado em: (2020)

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis : is the reason to switch relevant?
por: Manica, Santiago Rodrigues
Publicado em: (2020)

Muscle dysfunction in axial spondylarthritis: the MyoSpA study
por: Neto, A.
Publicado em: (2022)

Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors
por: Ørnbjerg, Lykke M.
Publicado em: (2023)

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis
por: Machado, Pedro M
Publicado em: (2023)

Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis : going beyond BASDAI
por: Marona, Jose
Publicado em: (2020)

The effect of exercise and tumor necrosis factor inhibitor on peripheral and axial inflammation in an animal model of spondyloarthritis
por: Sofio, Ana Rita Durão da Graça Godinho
Publicado em: (2019)

Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI
por: Marona, Jose
Publicado em: (2020)

Subclinical Hypothyroidism on the Elderly
por: Macedo Silva, Sofia
Publicado em: (2018)